I'm about to turn 40, and I'm nervous about getting my first mammogram. I hear they can be uncomfortable or even painful. Is ...

There was an outpouring of support when the six-time Olympic gold medalist revealed last month that he had been handed a ...

There's a new blood test to screen for colorectal cancer, but a new study found it's not as effective as a colonoscopy or ...

Clairity, Inc., a pioneer in AI-based predictive tools for breast cancer, is pleased to announce the appointment of Jeffrey R. Luber, JD, MBA, as President, Chief Executive Officer and Director. Luber ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the ...

With Ambry Genetics in tow, Eric Lefkofsky's biotech startup hopes to accelerate its drive toward turning a profit.

Since the Olympian first revealed his diagnosis just over two weeks ago, NHS England has revealed an almost 700% increase in ...

Could the controversial COVID drug hydroxychloroquine be repurposed as a promising medication for cancer? Researchers believe ...

The company claims to use a technique called preimplantation genetic testing for polygenic risk (PGT-P ... told undercover ...

Tempus AI said it agreed to pay $375 million in cash and $225 million in shares to acquire genetic testing company Ambry Genetics. Ambry conducts hereditary cancer screening and currently serves as ...

Scientists pinpointed 80 gene variants, including eight tied to fatty acid metabolism, that may cause breast cancer in some people, new research suggests.

Actor James Van Der Beek recently announced he has the disease. Diagnoses in people younger than 55 have nearly doubled since ...